+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Allergy Immunotherapy Market by Treatment Type, Allergen Type, Immunotherapy Delivery Form, Technology Platform, Allergy Type, End User, Distribution Channel - Global Forecast to 2030- Product Image
Allergy Immunotherapy Market by Treatment Type, Allergen Type, Immunotherapy Delivery Form, Technology Platform, Allergy Type, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Allergy Immunotherapy Market by Treatment Type, Allergen Type, Immunotherapy Delivery Form, Technology Platform, Allergy Type, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4905050
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Allergy Immunotherapy Market grew from USD 1.86 billion in 2024 to USD 2.04 billion in 2025. It is expected to continue growing at a CAGR of 10.03%, reaching USD 3.30 billion by 2030.

Navigating the New Frontiers of Allergy Immunotherapy

Allergy immunotherapy has emerged as a pivotal intervention in managing hypersensitivity reactions and improving patient quality of life. As prevalence rates of allergic conditions continue to climb globally, the demand for treatments that address root causes rather than merely alleviating symptoms has intensified. This executive summary provides a high-level synthesis of market dynamics, technological advancements, regulatory developments, and strategic imperatives shaping the allergy immunotherapy landscape.

This introduction sets the stage for a thorough exploration of transformative shifts, tariff impacts, segmentation insights, regional dynamics, competitive positioning, and strategic recommendations. By outlining key trends and synthesizing critical data points, this report equips decision-makers with the context and clarity needed to navigate a rapidly evolving environment. Through a blend of primary interviews, secondary research, and rigorous analytical frameworks, the ensuing sections distill vast datasets into concise, actionable insights designed to support both short-term tactics and long-term strategic planning.

Emerging Dynamics Redefining Allergy Treatment Landscape

The allergy immunotherapy market is undergoing transformative shifts driven by technological innovation, evolving patient expectations, and a complex regulatory milieu. Novel digital health platforms that monitor treatment adherence and symptom progression are reshaping the patient experience. At the same time, precision medicine approaches are enabling tailored desensitization protocols that optimize efficacy while minimizing adverse events.

Regulatory agencies are updating guidelines to expedite approval pathways for advanced formulations and adaptive trial designs. This evolving framework accelerates time to market for breakthrough therapies, particularly those leveraging recombinant allergens or nanotechnology platforms. Simultaneously, the rise of combination regimens-pairing traditional subcutaneous injections with adjunctive biologics-reflects a broader industry move toward personalized, multi-modal interventions. Together, these forces are catalyzing the emergence of a more dynamic, patient-centric landscape that promises to redefine standards of care.

Assessing the Ramifications of 2025 United States Tariffs

The introduction of targeted tariffs by the United States in 2025 has created a challenging environment for allergy immunotherapy manufacturers and suppliers. Raw materials sourced internationally, including specialized biologic compounds and advanced excipients, now face elevated import duties that inflate production costs. These cost pressures are prompting firms to reevaluate global supply chains and consider near-sourcing strategies to preserve margin integrity.

In response, some organizations are negotiating long-term agreements with domestic suppliers to secure critical inputs at more predictable price points. Others are adjusting pricing strategies in key market segments to offset incremental duties while maintaining patient access. The tariff landscape is also accelerating investments in manufacturing automation and continuous production technologies, which can mitigate cost volatility over the medium term. Collectively, these shifts underscore the importance of agile, resilient supply chain models in sustaining competitive advantage.

Unlocking Market Potential through Detailed Segmentation

Insight into market segmentation reveals diverse growth drivers across multiple dimensions. Based on treatment type, patients are choosing between epicutaneous immunotherapy, oral immunotherapy, subcutaneous immunotherapy, and sublingual immunotherapy depending on convenience, safety profile, and efficacy data. Allergen type segmentation highlights the prominence of animal dander alongside dust mites and pollen, with food allergen therapies for egg, milk, peanut, and tree nut sensitivities gaining rapid traction. Within agent delivery form, distinctions between dermal patches, drops, injections, and tablets inform product development priorities and patient adherence strategies. Technology platform segmentation underscores the competitive edge offered by adjuvants, nanotechnology-based platforms, and recombinant allergens in optimizing immunogenicity and safety. When examining allergy type, the market encompasses interventions for allergic asthma, allergic rhinitis, atopic dermatitis, and urticaria, each with unique clinical pathways and payer considerations. End user segmentation spans homecare settings, hospitals, research and academic laboratories, and specialty clinics, reflecting the varied care environments in which immunotherapy is administered. Finally, distribution channel dynamics between hospital pharmacy, online pharmacy, and retail pharmacy shape access strategies and commercial models across regions.

Regional Perspectives Driving Global Market Trends

Regional dynamics offer nuanced perspectives on growth opportunities and access challenges. In the Americas, a mature healthcare infrastructure and robust reimbursement frameworks support rapid adoption of innovative immunotherapy products, although payers continue to demand real-world evidence of long-term outcomes. Europe, Middle East & Africa presents a patchwork of regulatory harmonization efforts alongside varied payer policies, requiring tailored market entry strategies and portfolio configurations. In Asia-Pacific, emerging economies are experiencing heightened prevalence of allergic conditions, driving demand for cost-effective, scalable immunotherapy solutions. Government initiatives to expand allergy care coverage in key markets such as China and India are accelerating investment, while partnerships between global firms and local manufacturers are unlocking new distribution channels. These regional insights inform strategic planning and resource allocation for global players seeking balanced growth.

Profiling Leading Innovators Shaping the Sector

Leading companies are leveraging differentiated pipelines, strategic partnerships, and M&A activity to solidify competitive positions. Major pharmaceutical players with established biologics expertise are advancing recombinant allergen candidates through late-stage clinical trials, while specialized biotech firms are pioneering nanotechnology-enhanced formulations that promise superior safety and tolerability. Collaborative alliances between device manufacturers and immunotherapy developers are enabling the co-development of smart delivery platforms that integrate digital adherence monitoring. Investment trends indicate a growing appetite for early-stage acquisitions of novel adjuvant technologies, reflecting the critical role of immune response enhancers in next-generation therapies. The convergence of R&D focus, capital deployment, and regulatory engagement across these organizations underscores a collective drive toward innovation, strategic consolidation, and patient-centric care models.

Strategic Actions for Industry Leadership

Industry leaders should adopt a multi-pronged approach to harness emerging opportunities and mitigate market challenges. First, diversifying supply chains through regional manufacturing partnerships and continuous production platforms will reduce exposure to tariff volatility and raw material shortages. Second, investing in advanced analytics and real-world evidence generation will strengthen payer negotiations and demonstrate long-term value propositions. Third, integrating digital health tools into immunotherapy protocols can enhance patient adherence, capture longitudinal outcomes data, and support value-based contracting. Fourth, pursuing strategic alliances with biotechnology firms and academic research centers will accelerate access to breakthrough adjuvants and nanotechnology platforms. Finally, aligning commercial and clinical teams to deliver seamless patient education programs will drive market penetration and foster brand differentiation in a crowded landscape.

Rigorous Research Framework Underpinning Insights

This research is underpinned by a robust methodology that integrates primary interviews, secondary data collection, and advanced analytical techniques. Subject-matter experts across clinical, regulatory, and commercial functions were interviewed to validate market drivers, barriers, and emerging trends. Secondary research included a comprehensive review of peer-reviewed publications, patent filings, regulatory filings, and corporate disclosures to construct a detailed landscape of technological innovations and competitive dynamics. Quantitative models were developed to analyze segmentation performance, tariff impact scenarios, and regional growth trajectories. All findings underwent a multi-tiered quality assurance process to ensure data consistency, accuracy, and relevancy. This rigorous framework ensures that the insights and recommendations presented are both defensible and directly applicable to strategic decision-making.

Synthesis of Critical Discoveries and Outlook

The allergy immunotherapy market stands at a critical inflection point defined by technological breakthroughs, evolving regulatory pathways, and shifting payer expectations. Enhanced segmentation capabilities reveal targeted opportunities across treatment types, allergen profiles, delivery forms, technology platforms, and care settings. The imposition of United States tariffs underscores the need for resilient supply chain strategies, while regional market analyses highlight the importance of localized approaches to market entry and expansion. Competitive profiling demonstrates a collective push toward innovation through recombinant technologies, nanotechnology platforms, and digital health integration. The strategic recommendations outlined provide a roadmap for navigating uncertainty and capturing growth in a dynamic landscape. Collectively, these insights equip stakeholders with the strategic clarity required to deliver patient-centric solutions and achieve sustainable market leadership.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Treatment Type
    • Epicutaneous Immunotherapy
    • Oral Immunotherapy
    • Subcutaneous Immunotherapy
    • Sublingual Immunotherapy
  • Allergen Type
    • Animal Dander
      • Cat Allergens
      • Dog Allergens
    • Dust Mites
    • Food Allergens
      • Egg Allergens
      • Milk Allergens
      • Peanut Allergens
      • Tree Nut Allergens
    • Pollen
  • Immunotherapy Delivery Form
    • Dermal Patch
    • Drops
    • Injections
    • Tablets
  • Technology Platform
    • Adjuvants
    • Nanotechnology-Based Platforms
    • Recombinant Allergens
  • Allergy Type
    • Allergic Asthma
    • Allergic Rhinitis
    • Atopic Dermatitis
    • Urticaria
  • End User
    • Homecare Settings
    • Hospitals
    • Research & Academic Laboratories
    • Specialty Clinics
  • Distribution Channel
    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Adamis Pharmaceuticals Corporation
  • ALK-Abelló, Inc.
  • Allergy Therapeutics PLC
  • Anergis SA
  • ASIT Biotech by DMS Imaging
  • ASIT Biotech SA
  • Biomay AG
  • Biomunex Pharmaceuticals SAS
  • BioSpace, Inc.
  • Circassia Group PLC
  • DBV Technologies SA
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • HAL Allergy B.V.
  • HollisterStier Allergy by Jubilant Pharma Company
  • Jubilant HollisterStier LLC
  • LETI Pharma, S.L.U.
  • Merck KGaA
  • Mylan N.V. by Viatris Inc.
  • NOVARTIS AG
  • Sanofi S.A
  • Stallergenes Greer International AG
  • Stallergenes Greer Ltd
  • Torii Pharmaceutical Co., Ltd.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Allergy Immunotherapy Market, by Treatment Type
8.1. Introduction
8.2. Epicutaneous Immunotherapy
8.3. Oral Immunotherapy
8.4. Subcutaneous Immunotherapy
8.5. Sublingual Immunotherapy
9. Allergy Immunotherapy Market, by Allergen Type
9.1. Introduction
9.2. Animal Dander
9.2.1. Cat Allergens
9.2.2. Dog Allergens
9.3. Dust Mites
9.4. Food Allergens
9.4.1. Egg Allergens
9.4.2. Milk Allergens
9.4.3. Peanut Allergens
9.4.4. Tree Nut Allergens
9.5. Pollen
10. Allergy Immunotherapy Market, by Immunotherapy Delivery Form
10.1. Introduction
10.2. Dermal Patch
10.3. Drops
10.4. Injections
10.5. Tablets
11. Allergy Immunotherapy Market, by Technology Platform
11.1. Introduction
11.2. Adjuvants
11.3. Nanotechnology-Based Platforms
11.4. Recombinant Allergens
12. Allergy Immunotherapy Market, by Allergy Type
12.1. Introduction
12.2. Allergic Asthma
12.3. Allergic Rhinitis
12.4. Atopic Dermatitis
12.5. Urticaria
13. Allergy Immunotherapy Market, by End User
13.1. Introduction
13.2. Homecare Settings
13.3. Hospitals
13.4. Research & Academic Laboratories
13.5. Specialty Clinics
14. Allergy Immunotherapy Market, by Distribution Channel
14.1. Introduction
14.2. Hospital Pharmacy
14.3. Online Pharmacy
14.4. Retail Pharmacy
15. Americas Allergy Immunotherapy Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Allergy Immunotherapy Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Allergy Immunotherapy Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Adamis Pharmaceuticals Corporation
18.3.2. ALK-Abelló, Inc.
18.3.3. Allergy Therapeutics PLC
18.3.4. Anergis SA
18.3.5. ASIT Biotech by DMS Imaging
18.3.6. ASIT Biotech SA
18.3.7. Biomay AG
18.3.8. Biomunex Pharmaceuticals SAS
18.3.9. BioSpace, Inc.
18.3.10. Circassia Group PLC
18.3.11. DBV Technologies SA
18.3.12. Eli Lilly and Company
18.3.13. F. Hoffmann-La Roche Ltd.
18.3.14. GlaxoSmithKline plc
18.3.15. HAL Allergy B.V.
18.3.16. HollisterStier Allergy by Jubilant Pharma Company
18.3.17. Jubilant HollisterStier LLC
18.3.18. LETI Pharma, S.L.U.
18.3.19. Merck KGaA
18.3.20. Mylan N.V. by Viatris Inc.
18.3.21. NOVARTIS AG
18.3.22. Sanofi S.A
18.3.23. Stallergenes Greer International AG
18.3.24. Stallergenes Greer Ltd
18.3.25. Torii Pharmaceutical Co., Ltd.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. ALLERGY IMMUNOTHERAPY MARKET MULTI-CURRENCY
FIGURE 2. ALLERGY IMMUNOTHERAPY MARKET MULTI-LANGUAGE
FIGURE 3. ALLERGY IMMUNOTHERAPY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 20. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. ALLERGY IMMUNOTHERAPY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. ALLERGY IMMUNOTHERAPY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ALLERGY IMMUNOTHERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY EPICUTANEOUS IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ORAL IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY CAT ALLERGENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DOG ALLERGENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DUST MITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY EGG ALLERGENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY MILK ALLERGENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY PEANUT ALLERGENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREE NUT ALLERGENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY POLLEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DROPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ADJUVANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY NANOTECHNOLOGY-BASED PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RECOMBINANT ALLERGENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGIC ASTHMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGIC RHINITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ATOPIC DERMATITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY URTICARIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RESEARCH & ACADEMIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 67. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 68. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 69. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 70. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 71. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 72. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 73. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 74. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 77. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 78. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 79. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 80. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 81. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 82. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 83. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 123. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 124. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 125. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 126. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 127. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 128. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 129. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 132. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 133. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 134. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 135. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 136. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 137. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 138. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 141. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 150. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 151. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 152. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 153. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 154. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 155. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 156. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 159. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 160. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 161. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 162. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 163. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 164. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 165. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. UNITED ARAB EMIRATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 168. UNITED ARAB EMIRATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 169. UNITED ARAB EMIRATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 170. UNITED ARAB EMIRATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. SAUDI ARABIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 177. SAUDI ARABIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 178. SAUDI ARABIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 179. SAUDI ARABIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 180. SAUDI ARABIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 181. SAUDI ARABIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 182. SAUDI ARABIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 183. SAUDI ARABIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. SAUDI ARABIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. SOUTH AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 186. SOUTH AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 187. SOUTH AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 188. SOUTH AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 189. SOUTH AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 190. SOUTH AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 191. SOUTH AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 192. SOUTH AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. SOUTH AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. DENMARK ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 195. DENMARK ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 196. DENMARK ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 197. DENMARK ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 198. DENMARK ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 199. DENMARK ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 200. DENMARK ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 201. DENMARK ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. DENMARK ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 208. NETHERLANDS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 209. NETHERLANDS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 210. NETHERLANDS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. NETHERLANDS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. QATAR ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 213. QATAR ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 214. QATAR ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 215. QATAR ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 216. QATAR ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 217. QATAR ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 218. QATAR ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 219. QATAR ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. QATAR ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 221. FINLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 222. FINLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 223. FINLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 224. FINLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 225. FINLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 226. FINLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 227. FINLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 228. FINLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. FINLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. SWEDEN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 231. SWEDEN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 232. SWEDEN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 233. SWEDEN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 234. SWEDEN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 235. SWEDEN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 236. SWEDEN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 237. SWEDEN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. SWEDEN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 244. NIGERIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 245. NIGERIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 246. NIGERIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. NIGERIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 248. EGYPT ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 249. EGYPT ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 250. EGYPT ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 251. EGYPT ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 252. EGYPT ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 253. EGYPT ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 254. EGYPT ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 255. EGYPT ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. EGYPT ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 257. TURKEY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 258. TURKEY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 259. TURKEY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 260. TURKEY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 261. TURKEY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 262. TURKEY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 263. TURKEY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 264. TURKEY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. TURKEY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 266. ISRAEL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 267. ISRAEL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 268. ISRAEL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 269. ISRAEL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 270. ISRAEL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 271. ISRAEL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 272. ISRAEL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 273. ISRAEL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. ISRAEL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 275. NORWAY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 276. NORWAY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 277. NORWAY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 278. NORWAY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 279. NORWAY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 280. NORWAY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 281. NORWAY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 282. NORWAY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. NORWAY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 284. POLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 285. POLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 286. POLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 287. POLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 288. POLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 289. POLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 290. POLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 291. POLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 292. POLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 293. SWITZERLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 294. SWITZERLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 295. SWITZERLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 296. SWITZERLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 297. SWITZERLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 302. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 303. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 304. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 305. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 306. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 307. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 308. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 309. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 310. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 311. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 312. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 313. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 314. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 315. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 316. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 317. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 318. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 319. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 320. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 321. INDIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 322. INDIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 323. INDIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 324. INDIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 325. INDIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 326. INDIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 327. INDIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (US

Companies Mentioned

The companies profiled in this Allergy Immunotherapy market report include:
  • Adamis Pharmaceuticals Corporation
  • ALK-Abelló, Inc.
  • Allergy Therapeutics PLC
  • Anergis SA
  • ASIT Biotech by DMS Imaging
  • ASIT Biotech SA
  • Biomay AG
  • Biomunex Pharmaceuticals SAS
  • BioSpace, Inc.
  • Circassia Group PLC
  • DBV Technologies SA
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • HAL Allergy B.V.
  • HollisterStier Allergy by Jubilant Pharma Company
  • Jubilant HollisterStier LLC
  • LETI Pharma, S.L.U.
  • Merck KGaA
  • Mylan N.V. by Viatris Inc.
  • NOVARTIS AG
  • Sanofi S.A
  • Stallergenes Greer International AG
  • Stallergenes Greer Ltd
  • Torii Pharmaceutical Co., Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.04 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.3 Billion
Compound Annual Growth Rate10.0%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Allergy Immunotherapy Market Report and Forecast 2024-2032 - Product Image

Allergy Immunotherapy Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Allergy Immunotherapies Market Size, Share, Trends and Forecast by Treatment Type, Allergy Type, Distribution Channel, and Region, 2025-2033 - Product Image

Allergy Immunotherapies Market Size, Share, Trends and Forecast by Treatment Type, Allergy Type, Distribution Channel, and Region, 2025-2033

  • Report
  • 141 Pages
  • Global
From
Allergy Immunotherapy Market Size, Share & Trends Analysis Report By Treatment Type (Subcutaneous Immunotherapy) By Type, By Allergy Type, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Allergy Immunotherapy Market Size, Share & Trends Analysis Report By Treatment Type (Subcutaneous Immunotherapy) By Type, By Allergy Type, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Pollen Allergy Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Pollen Allergy Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Allergy Vaccine Market by Route Of Administration, Allergens Targeted, Vaccine Type, Distribution Channel, Technology, Patient Age Group, End User - Global Forecast to 2030 - Product Image

Allergy Vaccine Market by Route Of Administration, Allergens Targeted, Vaccine Type, Distribution Channel, Technology, Patient Age Group, End User - Global Forecast to 2030

  • Report
  • 198 Pages
  • Global
From

About the Allergy Immunotherapy Market

Allergy Immunotherapy is a form of treatment for allergies that involves administering small doses of allergens to the patient over a period of time. This helps the patient build up a tolerance to the allergens, reducing the severity of their allergic reactions. Allergy Immunotherapy is often used in conjunction with other forms of allergy treatment, such as antihistamines and decongestants. Allergy Immunotherapy is a growing market, with a variety of products available to treat different types of allergies. These products range from sublingual drops and tablets to injections and nasal sprays. Many of these products are available over the counter, while others require a prescription from a doctor. The Allergy Immunotherapy market is highly competitive, with many companies offering products to treat different types of allergies. Some of the major players in the market include ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, and Circassia. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.